ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q2Scopus Q2SCImago #12,539Hybrid

Pharmaceutical Development and Technology

Acronym:lpdt
•
Abbreviation (ISO):PHARM. DEV. TECHNOL
•
Identifier (ISSN):1083-7450(Print)/1097-9867(Online)
•
Publisher:Informa Healthcare
Clarivate IF (2026)
2.9↑ +0.4
Journal Impact Factor
IF Trend↓
WoS Quartile
Q2
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Pharmaceutical Development and Technology

WoS Q2
13461.9520182.3520192.1720203.1320213.9220223.420232.620242.520252.92026
Annual Impact Factor Metric
Current (2026):2.9
Scopus SJR & RankScopus Q2
0.471
#12,539

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
79

79 papers with at least that number of citations each

WoS: SCIE / JCRQ2
Self-Citation Rate3.8%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
83articles/year
3.42% Gold OA•86.6% Original Research

Aims & Scope

Pharmaceutical Development & Technology publishes research on the design, development, manufacture, and evaluation of conventional and novel drug delivery systems, emphasizing practical solutions and applications to theoretical and research-based problems. The journal aims to publish significant, innovative and original research to advance the frontiers of pharmaceutical development and technology. Through original articles, reviews (where prior discussion with the EIC is encouraged), short reports, book reviews and technical notes, Pharmaceutical Development & Technology covers aspects such as: -Preformulation and pharmaceutical formulation studies -Pharmaceutical materials selection and characterization -Pharmaceutical process development, engineering, scale-up and industrialisation, and process validation -QbD in the form a risk assessment and DoE driven approaches -Design of dosage forms and drug delivery systems -Emerging pharmaceutical formulation and drug delivery technologies with a focus on personalised therapies -Drug delivery systems research and quality improvement -Pharmaceutical regulatory affairs This journal will not consider for publication manuscripts focusing purely on clinical evaluations, botanicals, or animal models.

Topics Covered (Recognized by AI)
Chemistry96.9%Biology90.3%Organic chemistry82.7%Materials science82.4%Engineering79.3%Physics72.4%Medicine72.3%Chemical engineering70.1%Chromatography70%Biochemistry62.3%Pharmacology58.5%Composite material55.3%Physical chemistry45.9%Nanotechnology41.2%Quantum mechanics39.9%Genetics37.1%Bioinformatics36.2%Thermodynamics34.1%Internal medicine33.6%Geology33.4%Nuclear magnetic resonance31.1%Psychology29.1%Polymer27.4%Paleontology26.3%Psychiatry25.6%Drug22.6%Drug delivery20.9%Dosage form20.8%
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

PHARMACOLOGY & PHARMACY

Q2
Rank173/356
IndexSCIE
JCISCIE2026

PHARMACOLOGY & PHARMACY

Q2
Rank135/356
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF2.9
Articles / Year67
Total Citations16
2025
IF2.5
Articles / Year109
Total Citations270
2024
IF2.6
Articles / Year107
Total Citations531
2023
IF3.4
Articles / Year85
Total Citations737
2022
IF3.915
Articles / Year91
Total Citations1,006

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #12,539Scopus Q2SCImago Profile
Scopus Coverage:1996-2026
Scopus Broad Areas:MedicinePharmacology, Toxicology and Pharmaceutics
Scopus Citation Rank (SJR)Q2
0.471

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q2
Citations / Doc (2 years)
2.95

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$2,908 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations917
3-Year Documents288
Citable Documents284

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate50.5%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Pharmaceutical ScienceQ2
Medicine (miscellaneous)Q3
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 3.8%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
4区 (Zone 4)Medicine
Minor Category (Specific Field):
4区PHARMACOLOGY & PHARMACY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Pharmaceutical Development and Technology (acronym: lpdt, abbr: PHARM. DEV. TECHNOL, ISSN: 1083-7450) is a peer-reviewed international scholarly journal in the field of Medicine, published by Informa Healthcare in United States since 1996. The periodical holds a Journal Impact Factor (JIF) of 2.90, ranking in quartile Q2 of Web of Science (SCIE), a Scopus SJR indicator of 0.471 (Q2), an H-index of 79.

The journal enforces rigorous peer evaluation with a publication frequency of Bimonthly, an annual output of approximately 83 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $2,908 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
Informa Healthcare
Publication Language
English
Frequency
Bimonthly
Founding Year
1996
Indexing & Databases
SCIEScopusPubMed
Editorial Address
TAYLOR & FRANCIS INC, 325 CHESTNUT ST, SUITE 800, PHILADELPHIA, USA, PA, 19106

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 6519feb3-9f9d-4969-a0f7-5fa271944acd
Database Updated: 2026-09-28